Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is an antacid combination product containing aluminum hydroxide and magnesium hydroxide as active ingredients, developed and manufactured by Chemidrug (a division of the Saakha Group) in Nepal. It is a small molecule pharmaceutical that works as a non-systemic antacid, directly neutralizing gastric acid in the stomach to provide rapid relief from acid-related symptoms such as heartburn, acid indigestion, and upset stomach. The combination of aluminum hydroxide and magnesium hydroxide is designed to balance gastrointestinal side effects while effectively increasing gastric pH. While this type of antacid combination is widely available under various brand names globally, Chemidrug markets it as an approved generic medicine within the Nepalese market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aluminium hydroxide + magnesium hydroxide.